Back to User profile » Dr Ranjit Ranbhor

Papers published by Dr Ranjit Ranbhor:

Perspectives

Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Development

Ranbhor R, Kulkarni P

Biologics: Targets and Therapy 2026, 20:581013

Published Date: 10 February 2026

Review

Advancing Monoclonal Antibody Manufacturing: Process Optimization, Cost Reduction Strategies, and Emerging Technologies

Ranbhor R

Biologics: Targets and Therapy 2025, 19:177-187

Published Date: 9 April 2025

Original Research

Evaluating Biosimilar Development Projects: An Analytical Framework Utilizing Net Present Value

Ranbhor R, Kulkarni P

Biologics: Targets and Therapy 2025, 19:125-135

Published Date: 25 March 2025

Review

Enzymatic Routes for Chiral Amine Synthesis: Protein Engineering and Process Optimization

Vikhrankar SS, Satbhai S, Kulkarni P, Ranbhor R, Ramakrishnan V, Kodgire P

Biologics: Targets and Therapy 2024, 18:165-179

Published Date: 25 June 2024